Position in VCEL
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$2,229,660
+$619,681 QoQ
Shares Held
50,116
+0.1% QoQ
Ownership
0.098%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#104
of 317 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VCEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Madison Asset Management, LLC holds $111,090,317 across 6 Biotechnology names. VCEL ranks #5 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
1,063,473 | $75,134,367 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
29,302 | $14,555,182 | |
| 3 | ARMP |
Armata Pharmaceuticals, Inc.
|
2,107,175 | $13,654,494 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
5,729 | $3,572,260 | |
| 5 | VCEL |
Vericel Corp
This page
|
50,116 | $2,229,660 | |
| 6 | GMAB |
Genmab A/S
|
70,781 | $1,944,354 |
All Filings in VCEL
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,229,660 | 50,116 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $1,609,979 | 50,046 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $1,819,153 | 50,518 | Shares | Sole | 2026-02-04 | |
| No filing history on record for this holder in this stock. | ||||||